Nitric oxide, the endothelium, pregnancy and pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 1, 1996, Pages 4-15

  Morris, Nicholas H ^a   Eaton, Bryan M ^b   Dekker, Guus ^c  

^a Rosie Maternity Hospital   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ENDOTHELIUM; FEMALE; FETUS; FETUS CIRCULATION; HUMAN; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; VASODILATATION;

BLOOD CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; FETUS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRE-ECLAMPSIA; PREGNANCY;

EID: 0030065618     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09508.x     Document Type: Review

References (152)

1. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557–1558.
2. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancer 1992; 339: 572–575.
3. Vallance P, Collier J. Biology and clinical relevance of nitric oxide. BMJ 1994; 309: 453–457.
4. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–142.
5. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249–258.
6. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–376.
7. Moncada S, Higgs A. The L-arginine nitric oxide pathway. N Engl J Med 1993; 329: 2002–2012.
8. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhari G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265–9269.
9. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–526.
10. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–666.
11. Schmidt HHHW, Nau H, Wittfoht W et al. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol 1988; 154:213–216.
12. Palmer RM, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric-oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251–1256.
13. Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A. EPR characterisation of molecular targets for NO in mammalian cells and organelles. FASEB J 1993; 1: 1124–1134.
14. Ignarro LJ. Biosynthesis and metabolism of endothium-derived nitric oxide. Ann Rev Pharmacol Toxic01 1990; 30: 535–569.
15. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 1987; 14: 3203–3207.
16. Ånggård, EE. Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199–1206.
17. Stuehr DJ, Fasehun OA, Kwon NS. et al. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyl eneiodonium and its analogs. FASAB J 1991; 5: 98–103.
18. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682–685.
19. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest 1993; 91: 437–442.
20. Luscher TF. The endothelium, target and promotor of hypertension Hypertension 1990; 15: 482–485.
21. Vanhoutte PM. Endothelium and control of vascular function. Hypertension 1989; 13: 658–667.
22. Weiner C. Martinez E, Zhu LK, Ghodsi A, Chestnut D. In vitro release of endothelium-derived relaxing factor by acetylcholine is increased during the guinea pig pregnancy. Am J Obstet Gynecol 1989; 161: 1599–1605.
23. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Nail Acad Sci USA 1994; 91: 5212–5216.
24. Conrad KP, Vernier KA. Plasma level, urinary excretion and metabolic production of cGMP during gestation in rats. Am J Physiol 1989; 257: R847–R853.
25. Conrad KP, Joffe GM, Kruszyna H et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASAB J 1993; 7, 566–571.
26. Yallampalli C, Izumi H, Byam-Smith M, Garfield RE. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol 1993; 170: 175–185.
27. Yallampalli C, Izumi H, Byam-Smith M, Garfield RE. Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology 1993; 133: 1899–1902.
28. Izumi H, Yallampalli C, Garfield RE, Gestational changes in L-arginine-induced relaxation of pregnant rat and human myometrial smooth muscle. Am J Obstet Gynecol 1990; 169: 1327–1337.
29. Natuzzi ES, Ursell PC, Buscher C, Riemer RK. Nitric oxide synthase activity in the pregnant uterus decreases at parturition. Biochem Biophys Res Commun 1993; 194: 1–8.
30. Sladek SM, Regenstein AC, Lykins D, Roberts JM. Nitric oxide synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy. Am J Obstet Gynecol 1993; 169: 1285–1291.
31. Sooranna SR, Johnson MR, Steer PJ. Nitric oxide synthase activity in human myometrium. Placenta 1994; 15: A 67.
32. Morris NH, Carroll S, Nicolaides KH, Steer PJ, Warren JB. Exhaled NO concentration and amniotic fluid nitrite concentration in pregnancy. Eur J Clin Invest 1995; 25: 138–141.
33. Buhimschi I, Yallampalli C, Dong YL, Garfield RE. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol 1995; 172: 1577–1584.
34. Conrad KP, Vill M, Mcguire PG, Dail WG, Davis AK. Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. FASEB J 1993; 7: 1269–1276.
35. Morris NH, Sooranna SR, Eaton BM, Steer PJ. NO synthase activity in placental bed and tissues from normotensive pregnant women. Lancet 1993; 342: 679–680.
36. Myatt L, Brockman DE, Langdon G, Pollock JS. Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta 1993; 14: 373–383.
37. Myatt L, Brockman DE, Eis AL, Pollock JS. Immunohisto-chemical localization of nitric oxide synthase in the human placenta. Placenta 1993; 14: 487–495.
38. Buttery LDK, McCarthy A, Springall A et al. Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 1994; 15: 257–267.
39. Garvey EP, Tuttle JV, Covington K et al. Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophys 1994; 311: 235–241.
40. Morris NH, Cooper JC, Lepper M, Robichaud A, Sooranna SR, Rowbottom A. mRNA expression for inducible nitric oxide synthase (iNOS) in normotensive pregnancy and in pregnancy complicated by pre-eclampsia. Proceedings of the International Study of Hypertension in Pregnancy; 1995; A3–3.
41. Henderson AH. Endothelium in control. Br Heart J 1991; 65: 116–125.
42. Warren JB. In: Warren JB, editor. The Endothelium: an Introduction to Clinical Research. New York: Wiley-Liss Inc.
43. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986; 8: 37–44.
44. Holtz J, Giesler M, Bassenge E. Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo: indirect, flow-dependent, endothelium mediated dilation and direct smooth muscle relaxation. Z Kardiol 1983; 72 (3 Suppl), 98–106.
45. Colman RW, Marder VJ, Salzman EW, Hirsch J. Overview of hemostasis. In: Colman RW, Hirsch J, Marder VJ, Salzman EW, editors. Hemostasis and Thrombo Basic Principles and Clinical Practice. Philadelphia: Lippincott, 1994; 3–18.
46. Vane JR, Ånggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27–36.
47. Gant NF, Daley GI, Chand S, Whalley PJ, MacDonald PC. Control of vascular reactivity in pregnancy. Am J Clin Invest 1987; 52: 2682–2689.
48. Everett RB, Worley RJ, MacDonald PC, Gant NF. Effect of prostaglandin synthetase inhibitors on pressor responses to angiotensin II in human pregnancy. J Clin Endocrinol Metab 1978; 46: 1007–1010.
49. Venuto R, Min I, Barone P, Donker A, Cunningham E. Blood pressure control in pregnant rabbits: norepinephrine and prostaglandin interactions. Am J Physiol 1984; 247: R786–R791.
50. Van Buren GA, Yang D, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obster Gynecol 1992; 167: 828–833.
51. Molnar M, Hertelendy F. N-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 1992; 166: 1560–1567.
52. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am J Obster Gynecol 1994; 170: 1458–1466.
53. Brosens I, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of pre-eclampsia. In: Wynn RM editor. Obstetrics and Gynecology Annual. New York: Appleton-Century-Crofts. 1972; 177–191.
54. Kingdom JCP, Macara LM, Whittle MJ. Fetoplacental circulation in health and disease. Arch Dis Child 1994; 70: 161–162.
55. Hull AD, White CR, Pearce WJ. Endothelium-derived relaxing factor and cyclic GMP-dependent vasorelaxation in human chorionic plate arteries. Placenta 1994; 15: 365–375.
56. Chang JK, Roman C, Heymann MA. Effect of endothelium-derived relaxing factor inhibition on the umbilical-placental circulation in fetal lambs in utero. Am J Obster Gynecol 1992; 166: 727–734.
57. Myatt L, Brewer AS, Brockman DE. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991; 164: 687–692.
58. Myatt L, Brewer AS, Langdon G, Brockman DE. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol 1992; 166: 224–230.
59. Learmont JG, Braude PR, Poston L. Flow-induced dilation is modulated by nitric oxide in isolated human small fetoplacental arteries. J Vusc Res 1994; 31 (1 Suppl): 26.
60. Fitzgerald DJ, Rocki W, Murray R, Mayo G, Fitzgerald GA. Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 1990; 335: 751–754.
61. McLaren M, Greer IA, Walker JJ et al. Reduced prostacyclin production by umbilical arteries from pregnancies complicated by severe pregnancy-induced hypertension. Clin Exp Hypertens 1987; 2: 365–374.
62. Khong TY, de Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and small for gestational age infants. Br J Obstet Gynecol 1986; 93: 1049–1059.
63. Conrad KP, Colpoys MC. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. J Clin Invest 1986; 77: 236–245.
64. Sorensen TK, Easterling TR, Carlson KL, Brateng DA, Benedetti TJ. The maternal hemodynamic effect of indomethacin in normal pregnancy. Obstet Gynecol 1992; 79: 661–663.
65. Brown CEL, Cant NF, Cox K, Spitz B, Rosenfeld CR, Magness RR. Low dose aspirin. II. Relationship of angiotensin I1 pressor responses, circulating eicosanoids, and pregnancy outcome. Am J Obstet Gynecol 1990; 163: 1853–1861.
66. de Jong CLD, Dekker GA, Sibai BM. The renin-angiotensin-aldosterone system in preeclampsia: a review. Clin Perinatol 1991; 18: 683–711.
67. Zeeman GG, Dekker GA. Pathogenesis of pre-eclampsia. Clin Obstet Gynecol 1992; 35: 317–337.
68. Redman CW. The placenta, pre-eclampsia and chronic villitis. In: Redman CW, Sargent IL, Starkey PM, editors. The Human Placenta. Oxford: Blackwell Scientific Publications, 1993; 433–467.
69. 2 in maintaining low vascular tone in feto-placental vessels. Am J Physiol 1993; 265: H2036–H2043.
70. Chu ZM, Beilin LJ. Mechanisms of vasodilatation in pregnancy: studies of prostaglandin and nitric-oxide reactivity in the in situ blood perfused mesentery of pregnant rats. Br J Pharmacol 1993; 109: 322–329.
71. Diederich D, Skopec J, Diederich A, Fu-Xiang A. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 1994; 266: HI153–HI161.
72. Ahokas RA, Mercer BM, Sibai BM. Enhanced endothelium-derived relaxing factor activity in pregnant spontaneously hypertensive rats. Am J Obstet Gynecol 1991; 165: 801–807.
73. Harrison GL, Moore LG. Blunted vasoreactivity in pregnant guinea pigs is not restored by meclofenamate. Am J Obstet Gynecol 1989; 160: 258–264.
74. Lazarchick J, Stubbs TM, Romein L, van Dorsten JP, Loadholt CB. Predictive value of fibronectin levels in normotensive gravid women destined to become pre-eclamptic. Am J Obstet Gynecol 1986; 154: 1050–1052.
75. Rodgers GM, Taylor RN, Roberts JM. Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159: 908–914.
76. Rappaport VJ, Hirata G, Kim, Yap H, Jordan SC. Anti-vascular endothelial cell antibodies in severe preeclampsia. Am J Obstet Gynecol 1990; 162: 138–146.
77. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol 1991; 18: 661–682.
78. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome pre-eclampsia. Am J Hypertension 1991; 4: 700–708.
79. Roberts JM, Taylor RN, Goldfien A. Endothelial cell activation as a pathogenetic factor in preeclampsia. Semin Perinatol 1991; 15: 86–93.
80. Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol 1989; 161: 735–741.
81. Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia. II. Mitochondria1 changes. Am J Obstet Gynecol 1990; 163: 943–953.
82. Barton JR, Hiett AK, O'Connor WN, Nissen SE, Greene JW. Endomyocardial ultrastructural findings in pre-eclampsia. Am J Obstet Gynecol 1991; 165: 389–391.
83. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447–1451.
84. Kamoi K, Sudo N, Ishibashi M, Yamaji T. Plasma endothelin-1 levels in patients with pregnancy-induced hypertension. N Engl J Med 1990; 323: 1486–1487.
85. Taylor RN, Varma M, Teng NH, Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrin Metab 1990;71: 1675–1677.
86. Mitchell MD. Endothelins in perinatal biology. Semin Perinatol 1991; 15: 79–85.
87. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 1991; 165: 724–727.
88. Dekker GA, Krayenbrink AA, Zeeman GG, van Kamp GJ, Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1991; 40: 215–220.
89. Kraayenbrink AA, Dekker GA, van Kamp GJ, van Geijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol 1993; 169: 160–165.
90. Lockwood CJ, Peters JH. Increased plasma levels of EDI + cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 1990; 162: 358–362.
91. Ballegeer VC, Spitz B, de Baene LA, van Assche AF, Hidajat M, Criel AM. Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol 1992; 166: 629–633.
92. Hsu CF, Iriye B, Johnson TRB, Witter FR, Hong SF, Chan DW. Elevated circulating thrombomodulin in severe preeclampsia. Am J Obstet Gynecol 1993; 169: 148–149.
93. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994; 101: 488–492.
94. De Boer K, Lecander I, ten Cate, JW, Borm JJJ, Treffers PE. Placental-type plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol 1988; 158: 516–522.
95. Walsh SW. Pre-eclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985; 152: 335–340.
96. Dekker GA. Prediction and prevention of pregnancy-induced hypertensive disorders. A clinical and pathophysiologic study [academic thesis]. Rotterdam: Erasmus University. The Hague: Pasmans Press.
97. Robertson WB, Brosens L, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 1967; 93: 581–592.
98. Redman CWG. Pre-eclampsia and the placenta. Placenta 1991; 12: 301–308.
99. Jones CJ, Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1980; 1: 61–76.
100. Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol 1991; 98: 973–979.
101. Smarason AK, Sargent IL, Starkey PM, Redman CWG. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynecol 1993; 100: 943–949.
102. Harlan JD. Neutrophil-mediated vascular injury. Acta Med Srand 1987; 75: 123–129.
103. Lam BK, Austen KF. Leukotrienes; biosynthesis, release and actions. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, 1992; 139–147.
104. Greer IA, Dawes J, Johnston TA, Calder AA. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol 1991; 78: 28–32.
105. Butterworth BH, Greer IA, Liston WA, Haddad NG, Johnston TA. Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. Br J Obstet Gynaecol 1991; 98: 929–933.
106. Starkey PM. The decidua and factors controlling placentation. In: Redman CW, Sargent LL, Starkey PM, editors. The Human Placenta. Oxford: Blackwell Scientific Publications, 1993; 362–413.
107. Tsukimori K, Maeda H, Ishida K, Nagata H, Koyanagi T, Nakano H. The superoxide generation of neutrophils in normal and pre-eclamutic pregnancies. Obstet Gynecol 1993; 81: 536–540.
108. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JC. The cell adhesion molecule VCAM-I is selectively elevated in the serum in pre-eclampsia. Br J Obstet Gynecol 1994; 101: 485–487.
109. Fay RA, Hughes AO, Farron NT. Platelets in pregnancy: hyperdestruction in pregnancy. Obstet Gynecol 1983; 61: 238–240.
110. Gerbasi FR, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 1990; 75: 385–389.
111. Whigham KAE, Howie PW, Drummond AH, Prentice CRM. Abnormal platelet function in pre-eclampsia. Br J Ubster Gynaecol 1978; 85: 28.
112. Redman CWG, Bonnar J, Beilan L. Early platelet consumption in pre-eclampsia. BMJ 1978; 1: 467–469.
113. Hardy E, Rubin PC, Horn EH. Effects of nitric oxide donors in vitro on the arachidonic acid-induced platelet release reaction and platelet cyclic GMP concentration in pre-eclampsia. Clin Sci 1994; 86: 195–202.
114. Middelkoop CM, Dekker GA, Kraayenbrink AA, Popp-Snijders C. Platelet-poor plasma serotonin in normal and pre-eclamptic pregnancy. Clin Chem 1993; 39: 1675–1678.
115. Seligman SP, Abramson SB, Young BK, Buyon JP. The role of nitric oxide in the pathogenesis of pre-eclampsia. Am J Obstet Gynecol 1994; 172: 944–948.
116. Davidge ST, Billiar TR, Roberts JM. Plasma nitrites and nitrates, stable end products of nitric oxide, are elevated in women with pre-eclampsia. Proceedings of the 9th International Conference ISSHP; 1994. A60–164.
117. Cameron IT, van Papendorp CL, Palmer RMJ. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy 1993; 12: 85–92.
118. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley, GStJ. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993; 342: 242–243.
119. Trudinger BJ, Giles WB, Cook CM. Flow velocity waveforms in the maternal uteroplacental and fetal umbilical placental circulations. Am J Obster Gynecol 1985; 152: 155–163.
120. Giles WB, Trudinger BJ, Baird PH. Fetal umbilical artery flow velocity waveforms and the placental vascular bed. Br J Ubstet Gynaecol 1985; 92: 31–38.
121. McGowan LM, Mullen BM, Ritichie JWK. Umbilical artery flow velocity waveforms and the placental vascular bed. Am J Obstet Gynecol 1989; 157: 900–902.
122. Morrow RJ, Adamson SL, Bull SN, Ritchie JW. Effect of placental embolisation on the umbilical artery velocity waveform in fetal sheep. Am J Obstet Gynecol 1989; 164: 1118–1126.
123. Copel JA, Schlafer D, Wentworth R et al. Does the umbilical artery systemic/diastolic ratio reflect flow or acidosis. Am J Obstet Gynecol 1990; 163: 751–756.
124. Schmidt KG, di Tommaso M, Silverman NH, Rudolph AM. Doppler echocardiographic assessment of fetal descending aortic and umbilical blood flows: validation in fetal lambs. Circulation 1991; 83: 1731–1733.
125. Morrow RJ, Adamson L, Ritchie K, Pearce M. The pathological basis of abnormal flow velocity waveforms. In: Pearce, M, editors. Doppler Ultrasound in Perinatal Medicine. London: Oxford University Press, 1992; 196–218.
126. Howard RB, Hosokawa T, Maguire MH. Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons. Am J Obstet Gynecol 1987; 157: 1261–1266.
127. Pinto A, Sorrentino R, Sorrentino P et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 164: 507–513.
128. Karsdorp VHM, van Vugt JMG, Jacobs C, Dekker GA, van Geijn HP. Amino acids, glucose and lactate concentrations in umbilical blood in relation to umbilical artery flow patterns. Eur J Ubstet Gynecol 1994; 57: 117–122.
129. Kovacs AG, Makary A, Peto J, Steinmetz G. Deficiency of c-GMP level in placental circulation in pregnancy-induced hypertensive disorders: possibility of decreased endothelium-derived relaxing factor. Hypertens Pregnancy 1994; 13: 163–169.
130. Morris NH, Sooranna SR, Ramsay B et al. Nitric oxide synthase activities in placental tissue from normotensive, pre-eclamptic and growth retarded pregnancies. Br J Obstet Gynaecol 1995; 102: 711–714.
131. McCarthy A, Patterson-Brown S, Raju K, Poston L. Functional properties of small placental arteries in relation to abnormal umbilical Doppler waveform analysis. Placenta 1993; 14: A 50.
132. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986; 78: 1–5.
133. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 1992; 260: 668–675.
134. Abrams J. Nitrates and nitrate tolerance in conjestive heart failure. Coronary Art Dis 1993; 4: 27–36.
135. Baker AB. Management of severe pregnancy-induced hypertension, or gestosis, with sodium nitroprusside. Anaesth Intensive Cure 1990; 18: 361–365.
136. Wasserstrum N. Nitroprusside in pre-eclampsia: circulatory distress and paradoxical bradycardia. Hypertension 1991; 18: 79–84.
137. De Rosdyro M, Nahrwold ML, Hill AB et al. Plasma levels and cardiovascular effects of nitroglycerin in pregnant sheep. Can Anaesth Soc J 1980; 27: 560–564.
138. Wheeler AS, James FM, Meis PJ et al. Effects of nitroglycerin and nitroprusside on the uterine vasculature of gravid ewes. Anesthesiology 1980; 52: 390–394.
139. Cotton DB, Longmire S, Jones MM, Dorman KF, Tessem J, Joyce TH. Cardiovascular alterations in severe pregnancy-induced hypertension: effects of intravenous nitroglycerin coupled with blood volume expansion. Am J Obstet Gynecol 1986; 154: 1053–1059.
140. Silver HM. Acute hypertensive crisis in pregnancy. Med Clin N Am 1989; 73(3): 623–638.
141. Longmire S, Leduc L, Jones MM, Hawkins JL, Joyce TH, Cotton DB. The hemodynamic effects of intubation during nitroglycerin infusion in severe preeclampsia. Am J Obstet Gynecol 1991; 164:551–556.
142. Giles WB, O'Callaghan S, Boura A, Walters W. Reduction in fetal umbilical-placental vascular resistance by glycerl trinitrate. Lancet 1992; 340: 856.
143. Grunewald C, Carlstrom K, Kublickas M. Nitroglycerin might improve umbilical circulation in preeclampsia. Hypertens Pregnancy 1994; 13: 327.
144. Ramsay B, de Belder A, Campbell S, Moncada S, Martin JF. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of preeclampsia. Eur J Clin Invest 1994; 24: 76–78.
145. Lees C, Campbell S, Jauniaux E et al. Arrest of preterm labour and prolongation of gestation with glycerol trinitrate, a nitric oxide donor. Lancet 1994; 343: 1325–1326.
146. De Belder AJ, Macallister R, Radomski M, Moncada S, Valance PJT. Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res 1994; 28: 691–694.
147. De Belder AJ, Lees C, Martin J, Moncada S, Campbell S. Treatment of HELLP syndrome with nitric oxide donor. Lancet 1995; 345: 124–125.
148. Abrams J. Interactions between organic nitrates and thiol groups. Am J Med 1991; 91 (3C Suppl): 106S–112S.
149. Lahera V, Khraibi AA, Romero JC. Sulfhydryl group donors potentiate the hypotensive effect of acetylcholine in rats. Hypertension 1993; 22: 156–160.
150. Raij L, Coffee K, Guerra J. Holmes D. Glomerula thrombosis in pregnancy: role of hypoargininemia and insufficient nitric oxide synthesis. Endothelium 1993; 1: 5.
151. Rossitch E, Alexander E, Black PM, Cooke JP. L-arginine normalizes endothelial function in cerebral vessels from hyper-cholesterolemic rabbits. J Clin Invest 1991; 87: 1295–1299.
152. Karitonov SA, Lubec G, Lubec B, Hjelm M, Barnes PJ. L-arginine increases exhaled NO in normal human subjects. Clin Sci 1995; 88: 135–139.